Kraj: Republika Południowej Afryki
Język: angielski
Źródło: South African Health Products Regulatory Authority (SAHPRA)
Pharmacare Limited û Woodmead
Not Indicated
Liquid
Each 5,0 mlcontains SODIUM VALPROATE 200,0 mg
Registered
2024-02-07
_ _ _ZA_NAVALIQ_2207_00 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _Page 1 of 22 _ 1.3.2 PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 NAVALPRO LIQUID 200 MG/5 ML SODIUM VALPROATE CONTAINS SWEETENERS: SACCHARIN SODIUM 4 MG, LIQUID SORBITOL 1 750 MG SORBITOL IS A SOURCE OF FRUCTOSE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING/ARE GIVEN NAVALPRO LIQUID • Keep this leaflet. You may need to read it again. • If you have further questions, please ask your doctor, pharmacist, nurse or other healthcare provider. • NAVALPRO LIQUID has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. WHAT IS IN THIS LEAFLET 1. What NAVALPRO LIQUID is and what it is used for 2. What you need to know before you take NAVALPRO LIQUID 3. How to take/give NAVALPRO LIQUID 4. Possible side effects 5. How to store NAVALPRO LIQUID 6. Contents of the pack and other information _ _ _ZA_NAVALIQ_2207_00 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _Page 2 of 22 _ 1. WHAT NAVALPRO LIQUID IS AND WHAT IT IS USED FOR NAVALPRO LIQUID belongs to a group of medicines called anticonvulsants or anti- epileptics. It is used to treat epilepsy (fits) in adults and children. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NAVALPRO LIQUID DO NOT TAKE/GIVE NAVALPRO LIQUID: • if you or your child are hypersensitive (allergic) to sodium valproate or any of the other ingredients of NAVALPRO LIQUID (listed in section 6), • if you are breastfeeding your baby (see section titled Pregnancy, breastfeeding and fertility). • if you are pregnant - _For the treatment of epilepsy: _ • if you or your female (girl) child are pregnant, unless there is no suitable alternative treatment (see section titled Pregnancy, breastfeeding and fertility), • if you or your female child are a female able to have a baby, you must not take NAVALPRO LIQUID unless you use an effective method of birth control (contraception) at all times during your treatment with NAVALPRO LIQUID and the condition Przeczytaj cały dokument
_ _ _ZA_NAVALIQ_2207_00 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _Page 1 of 36 _ 1.3.1.1 PROFESSIONAL INFORMATION FOR MEDICINE FOR HUMAN USE NAVALPRO LIQUID HAS A HIGH TERATOGENIC POTENTIAL AND WHEN USED IN PREGNANCY, MAY CAUSE VARIOUS MAJOR AND MINOR CONGENITAL ABNORMALITIES OF BODY ORGANS AND/OR BODY STRUCTURES AS WELL AS MAY HARM THE DEVELOPING BRAIN OF THE FOETUS RESULTING IN NEGATIVE EFFECTS IN CHILDHOOD WHICH MAY INCLUDE NEURODEVELOPMENTAL DISORDERS SUCH AS LATE WALKING AND TALKING, POOR LANGUAGE SKILLS, MEMORY PROBLEMS, LOWER INTELLECTUAL ABILITIES. EXPOSURE TO NAVALPRO LIQUID _IN UTERO_ IS ALSO ASSOCIATED WITH AN INCREASED RISK TO DEVELOP AUTISTIC SPECTRUM DISORDER, CHILDHOOD AUTISM AND ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD). NAVALPRO LIQUID TREATMENT SHOULD BE INITIATED AND SUPERVISED BY A MEDICAL PRACTITIONER EXPERIENCED IN THE TREATMENT OF EPILEPSY AND NAVALPRO LIQUID SHOULD NOT BE PRESCRIBED IF THE RELEVANT RISK MINIMISATION MEASURES/PREGNANCY PREVENTION PROGRAMME, CANNOT BE IMPLEMENTED AND SUPERVISED AND PATIENTS ARE NOT COMMITTED TO ADHERE TO THESE MEASURES (SEE SECTIONS 4.4 AND 4.6). SCHEDULING STATUS S3 1. NAME OF THE MEDICINE NAVALPRO LIQUID 200 mg/5 ml 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml of NAVALPRO LIQUID contains 200 mg sodium valproate. Preservatives: Sodium methyl parahydroxybenzoate 0,1 % _m/v _ Sodium propyl parahydroxybenzoate 0,04 % _m/v _ Contains sweeteners: _ _ _ZA_NAVALIQ_2207_00 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _Page 2 of 36 _ Saccharin sodium 4 mg Liquid sorbitol 1 750 mg Sorbitol is a source of fructose. For full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Liquid. NAVALPRO LIQUID is a clear, red coloured liquid. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS NAVALPRO LIQUID is indicated in children, adolescents and adults for: • the treatment of generalised epilepsy, particularly with the following patterns of seizures: o absence, o myoclonic, o tonic-clonic, o atonic, o mixed. • the treatment of partial epilepsy: o simple or complex Przeczytaj cały dokument